Adalimumab [adalimumab]
- Terms
-
Humira
-
Adalimumab-adbm
Adalimumab-atto
Amjevita
Cyltezo
D2E7 Antibody
Humira
A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS.
- DUI
- D000068879 MeSH Browser
- CUI
- M0422769
- RN
- FYS6T7F842
- History note
- 2016 (2002)
- Public note
- 2016; ADALIMUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2002-2015
Allowable subheadings
- AD
- administration & dosage 98
- AE
- adverse effects 60
- AN
- analysis 1
- BI
- biosynthesis 1
- BL
- blood 2
- CF
- cerebrospinal fluid 0
- CH
- chemistry 1
- CL
- classification 2
- DE
- drug effects 0
- EC
- economics 5
- GE
- genetics 0
- HI
- history 0
- IM
- immunology 3
- IP
- isolation & purification 0
- ME
- metabolism 1
- PK
- pharmacokinetics 7
- PD
- pharmacology 60
- PH
- physiology 0
- PO
- poisoning 0
- RE
- radiation effects 0
- TU
- therapeutic use 186
- TO
- toxicity 0
- UL
- ultrastructure 1
- UR
- urine 0